AVALON PHARMA

Middle East Pharmaceutical Industries Company

4016StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	460.48M	394.00M	338.44M	302.66M	287.22M
Cost of Revenue	174.71M	151.59M	134.74M	119.21M	113.47M
Gross Profit	285.78M	242.41M	203.70M	183.45M	173.76M
SG&A	177.35M	150.00M	127.59M	113.73M	97.74M
Operating Expenses	178.84M	153.12M	126.17M	114.04M	97.60M
Operating Income	106.93M	89.29M	77.53M	69.41M	76.16M
Interest Expense	-3.25M	-3.67M	-5.75M	-4.73M	-1.87M
Other Income/Expense	—	—	—	—	-1.08M
Pretax Income	103.74M	86.35M	71.44M	65.02M	70.46M
Income Tax	6.73M	6.50M	5.61M	5.57M	4.18M
Net Income	97.01M	79.85M	65.83M	59.45M	66.28M
EBITDA	119.12M	99.08M	85.14M	76.25M	82.86M
EBIT	106.93M	89.29M	77.53M	69.41M	76.16M
EPS (Basic)	4.85	3.99	3.29	2.97	3.31
EPS (Diluted)	4.85	3.99	3.29	2.97	3.31
DPS	—	2.00	—	—	—
Margins & Efficiency
Gross Margin %	+62.1%	+61.5%	+60.2%	+60.6%	+60.5%
EBITDA Margin %	+25.9%	+25.1%	+25.2%	+25.2%	+28.8%
Net Margin %	+21.1%	+20.3%	+19.5%	+19.6%	+23.1%
Revenue & Income
Revenue	460.48M	394.00M	338.44M	302.66M	287.22M
Revenue Growth (YoY)	+16.9%	+16.4%	+11.8%	+5.4%	-4.8%
Gain (Loss) on Sale of Assets	40.87K	120.77K	126.03K	77.16K	—
Gain (Loss) on Sale of Investments	—	—	—	—	-2.76M
Currency Exchange Gain (Loss)	18.61K	-39.24K	-470.43K	271.08K	—
Expenses & Provisions
Cost of Revenue	174.71M	151.59M	134.74M	119.21M	113.47M
Selling, General & Admin	177.35M	150.00M	127.59M	113.73M	97.74M
Operating Expenses	178.84M	153.12M	126.17M	114.04M	97.60M
Other Operating Expenses	23.14K	-421.77K	87.19K	179.87K	-138.27K
Interest Expense	-3.25M	-3.67M	-5.75M	-4.73M	-1.87M
Other Non Operating Income (Expenses)	—	—	—	—	-1.08M
D&A For EBITDA	12.19M	9.80M	7.61M	6.84M	6.70M
Profitability & Returns
Gross Profit	285.78M	242.41M	203.70M	183.45M	173.76M
Gross Margin	+62.1%	+61.5%	+60.2%	+60.6%	+60.5%
EBIT	106.93M	89.29M	77.53M	69.41M	76.16M
EBIT Margin	+23.2%	+22.7%	+22.9%	+22.9%	+26.5%
EBITDA	119.12M	99.08M	85.14M	76.25M	82.86M
EBITDA Margin	+25.9%	+25.1%	+25.2%	+25.2%	+28.8%
EBT Excluding Unusual Items	103.70M	85.58M	71.31M	64.95M	73.22M
Pretax Income	103.74M	86.35M	71.44M	65.02M	70.46M
Operating Income	106.93M	89.29M	77.53M	69.41M	76.16M
Operating Margin	+23.2%	+22.7%	+22.9%	+22.9%	+26.5%
Profit Margin	+21.1%	+20.3%	+19.5%	+19.6%	+23.1%
Net Income	97.01M	79.85M	65.83M	59.45M	66.28M
Net Income to Common	97.01M	79.85M	65.83M	59.45M	66.28M
Net Income Growth	+21.5%	+21.3%	+10.7%	-10.3%	-9.0%
Income Tax Expense	6.73M	6.50M	5.61M	5.57M	4.18M
Effective Tax Rate	+6.5%	+7.5%	+7.9%	+8.6%	+5.9%
Per Share & Capital
EPS (Basic)	4.85	3.99	3.29	2.97	3.31
EPS (Diluted)	4.85	3.99	3.29	2.97	3.31
EPS Growth	+21.5%	+21.3%	+10.7%	-10.3%	-9.0%
Dividend Per Share	—	2.00	—	—	—
Shares Outstanding (Basic)	20.00M	20.00M	20.00M	20.00M	20.00M
Shares Outstanding (Diluted)	20.00M	20.00M	20.00M	20.00M	20.00M
Free Cash Flow	73.74M	21.91M	71.82M	58.99M	25.28M
Free Cash Flow Margin	+16.0%	+5.6%	+21.2%	+19.5%	+8.8%
Free Cash Flow Per Share	3.69	1.10	3.59	2.95	1.26
Payout Ratio	+48.4%	+18.8%	+54.7%	+61.1%	+56.1%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	460.48M	394.00M	338.44M	302.66M	287.22M
Cost of Revenue	174.71M	151.59M	134.74M	119.21M	113.47M
Gross Profit	285.78M	242.41M	203.70M	183.45M	173.76M
SG&A	177.35M	150.00M	127.59M	113.73M	97.74M
Operating Expenses	178.84M	153.12M	126.17M	114.04M	97.60M
Operating Income	106.93M	89.29M	77.53M	69.41M	76.16M
Interest Expense	-3.25M	-3.67M	-5.75M	-4.73M	-1.87M
Other Income/Expense	—	—	—	—	-1.08M
Pretax Income	103.74M	86.35M	71.44M	65.02M	70.46M
Income Tax	6.73M	6.50M	5.61M	5.57M	4.18M
Net Income	97.01M	79.85M	65.83M	59.45M	66.28M
EBITDA	119.12M	99.08M	85.14M	76.25M	82.86M
EBIT	106.93M	89.29M	77.53M	69.41M	76.16M
EPS (Basic)	4.85	3.99	3.29	2.97	3.31
EPS (Diluted)	4.85	3.99	3.29	2.97	3.31
DPS	—	2.00	—	—	—
Margins & Efficiency
Gross Margin %	+62.1%	+61.5%	+60.2%	+60.6%	+60.5%
EBITDA Margin %	+25.9%	+25.1%	+25.2%	+25.2%	+28.8%
Net Margin %	+21.1%	+20.3%	+19.5%	+19.6%	+23.1%
Revenue & Income
Revenue	460.48M	394.00M	338.44M	302.66M	287.22M
Revenue Growth (YoY)	+16.9%	+16.4%	+11.8%	+5.4%	-4.8%
Gain (Loss) on Sale of Assets	40.87K	120.77K	126.03K	77.16K	—
Gain (Loss) on Sale of Investments	—	—	—	—	-2.76M
Currency Exchange Gain (Loss)	18.61K	-39.24K	-470.43K	271.08K	—
Expenses & Provisions
Cost of Revenue	174.71M	151.59M	134.74M	119.21M	113.47M
Selling, General & Admin	177.35M	150.00M	127.59M	113.73M	97.74M
Operating Expenses	178.84M	153.12M	126.17M	114.04M	97.60M
Other Operating Expenses	23.14K	-421.77K	87.19K	179.87K	-138.27K
Interest Expense	-3.25M	-3.67M	-5.75M	-4.73M	-1.87M
Other Non Operating Income (Expenses)	—	—	—	—	-1.08M
D&A For EBITDA	12.19M	9.80M	7.61M	6.84M	6.70M
Profitability & Returns
Gross Profit	285.78M	242.41M	203.70M	183.45M	173.76M
Gross Margin	+62.1%	+61.5%	+60.2%	+60.6%	+60.5%
EBIT	106.93M	89.29M	77.53M	69.41M	76.16M
EBIT Margin	+23.2%	+22.7%	+22.9%	+22.9%	+26.5%
EBITDA	119.12M	99.08M	85.14M	76.25M	82.86M
EBITDA Margin	+25.9%	+25.1%	+25.2%	+25.2%	+28.8%
EBT Excluding Unusual Items	103.70M	85.58M	71.31M	64.95M	73.22M
Pretax Income	103.74M	86.35M	71.44M	65.02M	70.46M
Operating Income	106.93M	89.29M	77.53M	69.41M	76.16M
Operating Margin	+23.2%	+22.7%	+22.9%	+22.9%	+26.5%
Profit Margin	+21.1%	+20.3%	+19.5%	+19.6%	+23.1%
Net Income	97.01M	79.85M	65.83M	59.45M	66.28M
Net Income to Common	97.01M	79.85M	65.83M	59.45M	66.28M
Net Income Growth	+21.5%	+21.3%	+10.7%	-10.3%	-9.0%
Income Tax Expense	6.73M	6.50M	5.61M	5.57M	4.18M
Effective Tax Rate	+6.5%	+7.5%	+7.9%	+8.6%	+5.9%
Per Share & Capital
EPS (Basic)	4.85	3.99	3.29	2.97	3.31
EPS (Diluted)	4.85	3.99	3.29	2.97	3.31
EPS Growth	+21.5%	+21.3%	+10.7%	-10.3%	-9.0%
Dividend Per Share	—	2.00	—	—	—
Shares Outstanding (Basic)	20.00M	20.00M	20.00M	20.00M	20.00M
Shares Outstanding (Diluted)	20.00M	20.00M	20.00M	20.00M	20.00M
Free Cash Flow	73.74M	21.91M	71.82M	58.99M	25.28M
Free Cash Flow Margin	+16.0%	+5.6%	+21.2%	+19.5%	+8.8%
Free Cash Flow Per Share	3.69	1.10	3.59	2.95	1.26
Payout Ratio	+48.4%	+18.8%	+54.7%	+61.1%	+56.1%